This page shows the latest Alzheimer news and features for those working in and with pharma, biotech and healthcare.
Lecanmab is being evaluated in the ongoing phase 3 Clarity Alzheimer's clinical trial. ... been waiting for new treatment options to address an underlying pathology of Alzheimer’s disease.
The charity has suggested creating a Dementia Medicines Taskforce in order to address diseases like Alzheimer's. ... Alzheimer's Research UK has shared its support for new plans from the UK government to make the UK a leader in delivering innovative
Conditions targeted in the research include Alzheimer’s disease, motor neurone disease, frontotemporal dementia and Parkinson’s disease. ... Established in 2017 by the Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK, the
The trial assessed TauRx’s lead investigative oral drug, HMTM, which has been tested in 598 people diagnosed with Alzheimer’s. ... He added: “Today with limited treatments for Alzheimer’s, the standard of care does not impact the underlying
The winners, Five Lives and Neurocast, were among ten finalists working to create tech solutions for Alzheimer’s disease. ... The competition, launched in late 2021, was created to help accelerate the identification of tech solutions to address the
The licence application for the treatment of mild cognitive impairment due to Alzheimer’s disease was made as part of the accelerated approval pathway programme. ... Alzheimer’s disease is a progressive and devastating disease with few treatment
More from news
Approximately 163 fully matching, plus 423 partially matching documents found.
Over the past two decades, Alzheimer’s drug discovery has largely focused on targeting the hallmark amyloid protein. ... other than the build-up of the hallmark Alzheimer’s proteins, amyloid and tau.
Future Alzheimer’s research. Three points of interest critical to future Alzheimer’s research became more crystalised as a result of these studies:. ... Despite their limitations, available outcome scales, such as the Alzheimer’s Disease Assessment
and Alzheimer’s diseases.
Tau is emerging as a target for drug development in Alzheimer’s, as well as other disorders like frontotemporal dementia. ... big diseases in the field, such as Alzheimer’s, is too limited to make near-term success likely.
By Andrew Harrison. A few years ago, when communicating the phase 3 data of a major trial in Alzheimer’s disease (AD), our prime goal was focused on accuracy of reporting ... Most of us will have experience of family or friends with Alzheimer’s or
More from intelligence
Approximately 10 fully matching, plus 41 partially matching documents found.
She has demonstrated real drive and talent across a wide range of disease areas including oncology, MS, diabetes and Alzheimer’s, making her ideally suited to help build successful breakthrough science
The new board will be chaired by Dr Keith McCullagh, Metrion’s non-executive chairman, and its members will include Dr David Reynolds, chief scientific officer at Alzheimer’s Research UK.
Prior to this, he was medical director, global medical affairs for Janssen's Alzheimer's disease immunotherapy unit from June 2011 to May 2013.
Alzheimer's disease.
In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics
More from appointments
Approximately 0 fully matching, plus 23 partially matching documents found.
The RISE study includes a research registry created to help ensure the LGBTQIA+ community is represented in Alzheimer’s research.
Alzheimer’s disease).
A glimmer of hope for Alzheimer’s patients, but at what cost? ... Alzheimer’s disease.
Caring for people with dementia on hospital wards. London: Alzheimer's Society; 2009. ... Dementia UK: report to the Alzheimer’s society. London: Alzheimer’s Society; 2014.
What key things do you need to remember to reach patients living with Alzheimer’s disease? ... Alzheimer’s disease mainly affects people over the age of 65, with the disease developing and symptoms changing over time.
More from PMHub
Approximately 6 fully matching, plus 25 partially matching documents found.
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...